AlzProtect SAS believes that Alzheimer's disease is caused by the loss of neuroprotective factors including APP intracellular domain and sAPP alpha, both of which are produced during the metabolism of amyloid precursor protein. The start-up is developing compounds that can stimulate the APP, increasing the production of neuroprotective compounds.
Batiment Biserte
1 Place de Verdun
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
